Mitomycin 2mg Injection$30.00
1–9 boxes
$30.00 each
10–24 boxes
8% off
25+ boxes
10% off
Mitomycin 2mg Injection
SKU GME1451Oncology Care
Product Introduction
Mitomycin 2mg is an antitumour antibiotic used in selected solid-cancer regimens. Mitomycin may also be administered directly into the bladder for suitable non-muscle-invasive bladder-cancer treatment.
How to use
The reconstituted medicine is administered intravenously or, for a bladder regimen, through a urinary catheter. These routes use different preparation and treatment procedures. Intravenous administration requires careful monitoring for leakage.
How it works
Mitomycin forms cross-links in DNA after activation within cells, preventing replication and suppressing tumour-cell growth.
Side effects
Delayed low blood counts, nausea and mouth soreness can occur with systemic treatment. Intravesical treatment can cause urinary irritation. Kidney injury, lung toxicity and tissue injury are important risks.
Important information
Blood-count suppression can be cumulative and delayed. Bladder perforation must be excluded before intravesical treatment. New breathlessness, reduced urine or unusual bruising needs assessment.
Uses
- Selected advanced solid cancers and appropriate intravesical bladder-cancer regimens.
Benefits
Can suppress susceptible tumour growth or reduce bladder-tumour recurrence in an appropriate local-treatment programme.
Does a bladder treatment have the same procedure as an intravenous dose?
No. Intravesical treatment is placed into the bladder through a catheter and follows a separate local-treatment protocol.
Why can blood tests continue for weeks after systemic treatment?
The marrow effect may be delayed, with a later fall in platelets or white cells.
What is haemolytic uraemic syndrome?
It is a serious combination of red-cell breakdown, low platelets and kidney injury that has been associated with systemic mitomycin.
Why is burning at the intravenous site urgent?
Leakage can cause serious tissue damage, so the infusion needs immediate assessment.
Intravesical: administered into the bladder. Antitumour antibiotic: a cytotoxic medicine class. Cumulative toxicity: toxicity that increases with repeated exposure.; AR: Mitomycin 2mg حقن; FR: Mitomycin 2mg injection; PT: Mitomycin 2mg injeção; ES: Mitomycin 2mg inyección; RU: Mitomycin 2mg инъекция; ID: Mitomycin 2mg suntikan; VI: Mitomycin 2mg thuốc tiêm; MS: Mitomycin 2mg suntikan; TL: Mitomycin 2mg iniksyon; ZH-SG: Mitomycin 2mg 注射剂